- Home
- MCRB vs FSP Comparison
MCRB vs FSP Comparison
Compare MCRB & FSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MCRB | FSP |
|---|---|---|
| Founded | 2010 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.2M | 33.3M |
| IPO Year | 2015 | 2001 |
Fundamental Metrics
Financial Performance| Metric | MCRB | FSP |
|---|---|---|
| Price | $2.12 | $0.45 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $17.00 | N/A |
| AVG Volume (30 Days) | 70.9K | ★ 1.0M |
| Earning Date | 11-04-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 2.33% |
| EPS Growth | N/A | ★ 15.69 |
| EPS | N/A | ★ N/A |
| Revenue | $789,000.00 | ★ $107,162,000.00 |
| Revenue This Year | N/A | $16.75 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.02 | $0.30 |
| 52 Week High | $29.98 | $1.41 |
Technical Indicators
Market Signals| Indicator | MCRB | FSP |
|---|---|---|
| Relative Strength Index (RSI) | 19.80 | 66.94 |
| Support Level | N/A | $0.43 |
| Resistance Level | $9.53 | $0.51 |
| Average True Range (ATR) | 0.21 | 0.03 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 13.73 | 97.17 |
Price Performance
Historical ComparisonAbout MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.
About FSP Franklin Street Properties Corp.
Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The principal revenue sources for its real estate operations include rental income from real estate leasing, property dispositions and fee income from asset/property management and development. The company provides asset management, property management, property accounting, investor and/or development services to its portfolio and Sponsored REIT through the company's subsidiaries.